Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Photochem Photobiol B ; 210: 111985, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32771915

RESUMO

It is estimated over 600 million pharyngotonsillitis (PT) cases worldwide per year and 30% of this total are caused by Streptococcus pyogenes with standard antibiotic treatment. Antimicrobial Photodynamic Therapy (aPDT) has been studied for the clinical research in infectious diseases. The study aim was to analyze the evolution of aPDT on inactivation of clinical strains of multiple cycles. S. pyogenes and clinical strains isolated from patients with PT were incubated with curcumin in formulation (2.25 mg/ml) and irradiated at 450 nm in Light fluence rates. A mortality was a measure of the counting colony forming units per milliliter (CFU/ml) surviving. Parameters of bacterial biofilm formation, uptake of photosensitizer (PS) and efficacy of antibiotics on survival of bacteria of each cycle were tested. The bacteria profile remains unchanged between 10 aPDT cycles was observed. The bacterial colony survival presented a reduction in capacity to form biofilm due adhesion of strains and PS uptake rate. The antibiotic remained efficient after aPDT cycles. Our in vitro results suggested a low-level of development of PDT resistance, however a decrease of photosensitizer uptake was observed. Furthermore, there is no cross effect on aPDT cycles and the first application of antibiotics.


Assuntos
Anti-Infecciosos/farmacologia , Doenças Faríngeas/tratamento farmacológico , Fármacos Fotossensibilizantes/uso terapêutico , Streptococcus pyogenes/efeitos dos fármacos , Biofilmes/efeitos dos fármacos , Curcumina/química , Curcumina/farmacologia , Curcumina/uso terapêutico , Humanos , Luz , Doenças Faríngeas/microbiologia , Doenças Faríngeas/patologia , Fotoquimioterapia , Fármacos Fotossensibilizantes/química , Streptococcus pyogenes/isolamento & purificação , Streptococcus pyogenes/fisiologia
2.
Biochem Pharmacol ; 180: 114201, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32822688

RESUMO

Perillaldehyde (PAE), a natural monoterpenoid agent extracted from Perilla frutescence, PAE has been reported to present various physiological capabilities, such as anti-inflammation, anti-oxidative and anti-fungal. In this study, we show that PAE exhibits strong antifungal activity against Candida albicans (C. albicans). C. albicans, a fungal pathogen with high incidence of antifungal resistance in clinical settings, is the major cause of oropharyngeal candidiasis (OPC). OPC is characterized by inflammatory immunological responses to fungal infections. Our in vitro results show PAE inhibited several virulence attributes of C. albicans including biofilm formation, yeast-to-hyphal transition and secreted aspartic proteinases (SAPs) gene expression. Using an experimental murine model of OPC, we found that PAE inhibited NLRP3 inflammasome assembly, reduced the excessive accumulation of ROS and prevented the p65 transfer in nuclear; processes all leading to reduced inflammation burden in the host. Together, this supports use PAE as a promising new agent to improve OPC.


Assuntos
Antifúngicos/uso terapêutico , Candida albicans/efeitos dos fármacos , Candidíase Bucal/tratamento farmacológico , Monoterpenos/uso terapêutico , Doenças Faríngeas/tratamento farmacológico , Animais , Antifúngicos/farmacologia , Candida albicans/fisiologia , Candidíase Bucal/patologia , Relação Dose-Resposta a Droga , Camundongos , Camundongos Endogâmicos C57BL , Monoterpenos/farmacologia , Doenças Faríngeas/microbiologia , Doenças Faríngeas/patologia , Distribuição Aleatória
3.
Eur Arch Otorhinolaryngol ; 276(1): 203-208, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30361788

RESUMO

OBJECTIVE: To evaluate the efficacy and safety of Chinese medicine in the treatment of adenoid hypertrophy in children. METHOD: Screening standard articles, extracting relevant data from meta-analysis, were analyzed by Revman5.1 software, by searching PubMed, Medline, VIP, Wan Fang and Chinese HowNet database 2006-2016 in traditional Chinese medicine treatment of children with adenoid literature. RESULTS: 206 articles met the inclusion criteria, of which ten were selected and included in the meta-analysis, and there were 803 patients. The results showed that the remission rate of the Chinese medicine treatment group was better than that of the Western medicine group. The combined effect of the amount of OR 2.06, 95% Cl (1.45, 2.96) and the combined effect of the amount of the test Z = 4.12, P < 0.00001 showed the recurrence of the disease was lower in traditional Chinese medicine treatment group than the Western medicine group. The combined effect of the amount of OR 3.05, 95% Cl (2.11, 4.56) and the combined effect of the amount of the test Z = 5.86, P < 0.00001 showed the total effective rate is high in the traditional Chinese medicine treatment group than the Western medicine group. The difference between the combined effect of the amount of OR 2.79, 95% Cl (1.78, 5.03) and the combined effect of the amount of the test of Z = 4.54, P < 0.00001 was statistically significant, which showed the treatment effect of Chinese medicine group is obviously better than the Western medicine group. CONCLUSION: The use of Chinese medicine for the treatment of children with adenoid hypertrophy has good clinical efficacy.


Assuntos
Tonsila Faríngea/patologia , Medicamentos de Ervas Chinesas/uso terapêutico , Medicina Tradicional Chinesa , Doenças Faríngeas/tratamento farmacológico , Criança , Humanos , Hipertrofia/tratamento farmacológico , Hipertrofia/patologia , Doenças Faríngeas/patologia , Resultado do Tratamento
4.
J Neurol Neurosurg Psychiatry ; 59(4): 438-41, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7561927

RESUMO

A 67 year old woman with a two year history of laryngopharyngeal dystonia, spasmodic dysphonia, and parkinsonism succumbed to Wernicke's encephalopathy and died six months later. Necropsy showed, besides Wernicke's encephalopathy, degenerative changes in selected thalamic nuclei (dorsomedial, pulvinar, and the medial geniculate bodies) and the inferior olives and numerous cerebellar torpedoes. The substantia nigra and basal ganglia were spared. Immunostaining for prion protein was negative. This patient indicated a new type of presentation of so-called pure thalamic degeneration, or more precisely thalamo-olivary degeneration.


Assuntos
Distonia/patologia , Doenças da Laringe/patologia , Degeneração Neural , Doenças Faríngeas/patologia , Doenças Talâmicas/patologia , Idoso , Feminino , Humanos , Espasticidade Muscular/patologia , Núcleo Olivar/patologia , Doença de Parkinson/patologia , Tálamo/patologia , Distúrbios da Voz/patologia , Encefalopatia de Wernicke/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA